Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 69.00
-2.00 (-2.82%)
Nov 13, 2026, 4:25 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 422.86 million as of November 13, 2026. It is the 30,693rd most valuable company in the world and the 211th biggest in Norway. Its market cap has increased by 321.80% in one year.
Market Cap
422.86M
Enterprise Value
318.12M
Revenue
24.31M
Global Rank
Country Rank
#211 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 422.86M, an increase of 126.85%. That is a compound annual growth rate of 120.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 422.86M | 92.31% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.73B |
| Thor Medical ASA | 1.72B |
| Nykode Therapeutics AS | 1.12B |
| ArcticZymes Technologies ASA | 1.10B |
| Lytix Biopharma ASA | 736.70M |
| Zelluna ASA | 467.32M |
| SoftOx Solutions AS | 275.29M |
| Arctic Bioscience AS | 68.47M |